SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022143
Filing Date
2022-08-11
Accepted
2022-08-11 17:21:49
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 804327
2 ex31-1.htm EX-31.1 17550
3 ex31-2.htm EX-31.2 18070
4 ex32-1.htm EX-32.1 7053
5 ex32-2.htm EX-32.2 7288
  Complete submission text file 0001493152-22-022143.txt   3891377

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hils-20220630.xsd EX-101.SCH 27832
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hils-20220630_cal.xml EX-101.CAL 35153
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hils-20220630_def.xml EX-101.DEF 120911
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hils-20220630_lab.xml EX-101.LAB 276619
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hils-20220630_pre.xml EX-101.PRE 213874
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 495455
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 221156992
SIC: 2834 Pharmaceutical Preparations